Defibrillator News and Research

Latest Defibrillator News and Research

AED failures may lead to cardiac arrest deaths

More than 1,000 cardiac arrest deaths over 15 years are connected to the failure of automated external defibrillators (AEDs); battery failure accounted for almost one-quarter of the failures. The study was published online last week in Annals of Emergency Medicine.

31 Aug 2011

BIOTRONIK Home Monitoring reduces inappropriate shocks, improves ICD battery longevity

BIOTRONIK, a leading manufacturer of implantable cardiac devices and the pioneer of wireless remote monitoring technology, announced today the first presentation of results from the ECOST randomized controlled trial.

30 Aug 2011

CMR predicts increased risk of sudden cardiac death in patients with myocardial infarction

Universitätsmedizin Berlin and Universität Leiden developed a method to identify a subgroup of patients with myocardial infarction that is at increased risk for sudden cardiac death.

30 Aug 2011

Philips to launch first sleep apnea mobile app at ESC 2011 congress

Royal Philips Electronics will provide clinicians from across the globe with a glimpse of future innovations designed to advance cardiac care, including the current management of cardiovascular disease (CVD) and associated cardiac conditions, during the 2011 Congress of the European Society of Cardiology (ESC), which opens today in Paris.

From Philips Healthcare 29 Aug 2011

European Journal of Heart Failure publishes results of BIOTRONIK Home-CARE clinical study

BIOTRONIK SE & Co. KG, a worldwide leader in manufacturing cardiac medical devices and pioneer of remote patient management solutions, announced today that results of the Home-CARE (Home Monitoring in Cardiac Resynchronization Therapy) clinical study were published in the European Journal of Heart Failure.

26 Aug 2011

Medtronic first quarter global revenue increases 7% to $4.049 billion

Medtronic, Inc. today announced financial results for its first quarter of fiscal year 2012, which ended July 29, 2011.

From Medtronic 23 Aug 2011

FDA approves Medtronic's IDE for Advisa DR MRI SureScan pacing system

Medtronic, Inc. today announced U.S. Food and Drug Administration approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin evaluating Advisa DR MRI SureScan pacing system.

From Medtronic 1 Aug 2011

New LEAP technique can restore heart rhythm in patients with atrial fibrillation

A high-amplitude, and often painful, electrical shock is the only currently available method for treating certain cases of chronic cardiac arrhythmia. But now a new technique using much weaker impulses has been developed by an international team of physicists and cardiologists, including Alain Pumir, CNRS researcher at the ENS Lyon physics laboratory.

28 Jul 2011

Athletic trainers and coaches bear major responsibility for preventing deaths

Colleges and high schools must follow an active strategy to preventing deaths among student athletes from exertional heat stroke (EHS) and other causes, according to an editorial in a recent issue of The Journal of Strength and Conditioning Research, official research journal of the National Strength and Conditioning Association.

27 Jul 2011

Clinipace Worldwide selected to manage Spectranetics' cardiovascular device clinical study

Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today that Spectranetics Corporation, a developer, manufacturer, marketer and distributer of single-use medical devices used in minimally invasive procedures within the cardiovascular system, has selected Clinipace to manage all aspects of a pivotal cardiovascular device clinical study that will serve as the basis for 510(k) notice submission.

20 Jul 2011

New low-energy method for terminating cardiac fibrillation

An international team of scientists from the Max-Planck-Institute for Dynamics and Self-Organization, Cornell University the Ecole Normale Supérieure de Lyon, the University Medicine Göttingen, the Rochester Institute of Technology, and the Institut Non-Linéaire de Nice have developed a new low-energy method for terminating life-threatening cardiac fibrillation of the heart.

14 Jul 2011

New less painful technique to end life-threatening heart fibrillations

Cornell scientists, in collaboration with physicists and physician-scientists in Germany, France and Rochester, N.Y., have developed a new - and much less painful and potentially damaging - method to end life-threatening heart fibrillations.

14 Jul 2011

Genetic variation associated with increased risk of sudden cardiac arrest

A study by a global consortium of physician-scientists has identified a genetic variation that may predispose people to double the risk of having a sudden cardiac arrest, a disorder that gives little warning and is fatal in about 95 percent of cases.

1 Jul 2011

Time reduction in pauses between CPR and electronic defibrillator shocks boosts survival

Reducing the intervals between giving cardiopulmonary resuscitation (CPR) and an electronic defibrillator shock after cardiac arrest significantly improves survival, according to UT Southwestern Medical Center emergency medicine doctors involved in an international study.

30 Jun 2011

Expert addresses need to improve risk stratification of heart failure patients eligible for ICD or CRT-D

Responding to a recent study showing that 40% of patients who receive CRT-ICD therapy do not benefit from the device (Sipahi, et al – 6/13/11), Wojciech Zareba, MD, PhD, stated that improving risk stratification of heart failure patients eligible for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D) is essential.

28 Jun 2011

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

Spectranetics Corporation today announces the first patient enrollment in the EXCITE ISR (EXCImer Laser Randomized Controlled Study for Treatment of FemoropopliTEal In-Stent Restenosis) clinical trial.

27 Jun 2011

BIOTRONIK to introduce Lumax DX system for complete atrial arrhythmia diagnosis

BIOTRONIK SE & Co. KG, a worldwide leader in manufacturing cardiac medical devices, announced today that the innovative new Lumax 540 VR-T DX single-chamber implantable cardiac defibrillator (ICD) and Linoxsmart S DX cardiac lead system will be launched this coming week at the EHRA EUROPACE electrophysiology congress in Madrid, Spain.

24 Jun 2011

Every second counts when performing cardiac arrest resuscitation

A new study has found the number of people who survive after suffering a cardiac arrest outside a hospital drops significantly if the pause between stopping CPR and using a defibrillator to administer an electric shock is longer than 20 seconds.

21 Jun 2011

Key heart failure therapies could prevent nearly 68,000 deaths each year

A national study has found that nearly 68,000 deaths potentially could be prevented each year by optimally implementing key national guideline-recommended therapies, including critical medications and cardiac devices, for all eligible heart failure patients.

7 Jun 2011

Spectranetics to showcase new advanced peripheral atherectomy simulation system at New Cardiovascular Horizons

Spectranetics Corporation today announced it will showcase a new advanced peripheral atherectomy simulation system at the New Cardiovascular Horizons meeting in New Orleans.

31 May 2011

Defibrillator News and Research

Latest Defibrillator News and Research

AED failures may lead to cardiac arrest deaths

BIOTRONIK Home Monitoring reduces inappropriate shocks, improves ICD battery longevity

CMR predicts increased risk of sudden cardiac death in patients with myocardial infarction

Philips to launch first sleep apnea mobile app at ESC 2011 congress

European Journal of Heart Failure publishes results of BIOTRONIK Home-CARE clinical study

Medtronic first quarter global revenue increases 7% to $4.049 billion

FDA approves Medtronic's IDE for Advisa DR MRI SureScan pacing system

New LEAP technique can restore heart rhythm in patients with atrial fibrillation

Athletic trainers and coaches bear major responsibility for preventing deaths

Clinipace Worldwide selected to manage Spectranetics' cardiovascular device clinical study

New low-energy method for terminating cardiac fibrillation

New less painful technique to end life-threatening heart fibrillations

Genetic variation associated with increased risk of sudden cardiac arrest

Time reduction in pauses between CPR and electronic defibrillator shocks boosts survival

Expert addresses need to improve risk stratification of heart failure patients eligible for ICD or CRT-D

Spectranetics initiates enrollment in EXCITE clinical trial against femoropopliteal IRS

BIOTRONIK to introduce Lumax DX system for complete atrial arrhythmia diagnosis

Every second counts when performing cardiac arrest resuscitation

Key heart failure therapies could prevent nearly 68,000 deaths each year

Spectranetics to showcase new advanced peripheral atherectomy simulation system at New Cardiovascular Horizons

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Defibrillator News and Research

Latest Defibrillator News and Research

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Fluidics in Modern Healthcare & Medical Device Innovation

Scaling 3D biology: Automation, imaging, and the future of high-throughput research

How does norepinephrine influence anxiety-related behaviours?

Newsletters you may be interested in